Reproductive endocrinology

Reduced breast cancer risk in women with a history of pre-eclampsia: implications of postmenopausal hormone therapy

J Clin Endocrinol MetabPublished Register-based cohort study

Main finding · Breast cancerResult — go to the resultAdjusted hazard ratio 0.89 95% CI 0.83–0.94

Authors' conclusion

BC risk is reduced in women with a history of pre-eclampsia. The MHT-associated increase in BC risk is similar among women with or without a history of pre-eclampsia.

Study context

Population
Women who had given birth in 1969–1993, Finland; follow-up for breast cancer (BC) (Finnish Cancer Register 1987–2023) and menopausal hormone therapy (MHT) use (National Reimbursement Register 1994–2019)age-matched cohort
Participants
31,688 vs 91,726
Exposure
Prior pre-eclampsia vs no pre-eclampsia; MHT users vs non-users
  • Prior pre-eclampsian = 31,688
  • Controlsn = 91,726reference
Outcome
BC risk
Methodological detailsnationwide, population-based, age-matched
  • Nationwide
  • Population-based
  • Age-matched

Main finding

Breast cancer

Adjusted hazard ratio

0.89

95% CI 0.83–0.94

Events by group

Prior pre-eclampsiavs Controls
aHR 0.89 (95% CI 0.83–0.94)

As reported in the abstract

Observational data: associations, not effects.

Further findings

BC risk with MHT use, by pre-eclampsia history

MHT use: BC risk rise in prior pre-eclamptic women
1.25, 1.12-1.40
MHT use: BC risk rise in control women
1.30, 1.18-1.42
Comparable MHT-associated BC risk rise in prior pre-eclamptic and control women
Increased risk with any MHT use seen in both cohorts already after 5 years
Primarily associated with estrogen-progestogen use; estrogen only not associated with BC risk in prior pre-eclamptic women

Clinical characteristics of pre-eclamptic pregnancy (e.g. severity)

No clinical characteristic predicted the magnitude of BC risk reduction

Original publication

Reduced breast cancer risk in women with a history of pre-eclampsia: implications of postmenopausal hormone therapy. J Clin Endocrinol Metab. Published 18 July 2026. doi:10.1210/clinem/dgag271

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.